[HLA-DM polymorphisms in Guizhou Han individuals].
Hong-Mei Jiang1, Yong-Xia Wang, Yong Wang
1Department of Clinical Microbiology and Immunology, Guiyang Medical College, Guiyang 550004, China. jhmzq@yahoo.com.cn
Yi Chuan = Hereditas
|September 10, 2008
Summary
Genetic polymorphisms in the HLA-DM gene were analyzed in Han individuals from Guizhou Province. The study reveals distinct allele frequencies, suggesting regional genetic variations in this important immune system locus.
Area of Science:
- Immunogenetics
- Human Leukocyte Antigen (HLA) complex
- Population genetics
Background:
- The Human Leukocyte Antigen (HLA) system plays a critical role in immune response and transplantation.
- HLA-DM genes (HLA-DMA and HLA-DMB) are crucial for antigen presentation.
- Understanding genetic polymorphisms in HLA loci is vital for population studies and disease association research.
Purpose of the Study:
- To investigate the genetic polymorphisms of HLA-DMA and HLA-DMB loci in a Han population from Guizhou Province.
- To determine the allele and genotype frequencies of HLA-DM genes in this specific population.
- To compare the genetic profile with other regional populations.
Main Methods:
- Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) technique was employed.
- Analysis was conducted on 125 healthy, unrelated Han individuals from Guizhou Province.
- Allele and genotype frequencies for HLA-DMA and HLA-DMB were calculated.
Main Results:
- Identified specific allele frequencies for HLA-DMA: DMA*0101 (0.720), DMA*0102 (0.242), and DMA*0103 (0.036).
- Determined allele frequencies for HLA-DMB: DMB*0101 (0.620), DMB*0102 (0.156), DMB*0103 (0.188), and DMB*0104 (0.036).
- Common genotypes for DMA were DMA*0101/0101 and 0101/0102; for DMB, they were DMB*0101/0101, 0101/0102, and 0101/0103.
Conclusions:
- The genetic polymorphism of the HLA-DM gene in the Han individuals from Guizhou Province exhibits distinct characteristics.
- These findings highlight regional genetic variations within the Han population concerning HLA-DM loci.
- The data contribute to the understanding of HLA diversity in Chinese populations.
Related Concept Videos
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...